Latest Approved Drugs

Latest Approved Drugs
0 Comments
Drug Name Generic Treatment
Xadago Safinamide To treat Parkinson’s disease
Osmolex ER Amantadine HCL Treatment of Parkinson’s disease and drug-induced extrapyramidal reactions
Ocrevus Ocrelizumab To treat patients with relapsing and primary progressive forms of multiple sclerosis
Abilify MyCite Aripiprazole tablets with sensor First FDA-approved that digitally tracks if patients have ingested their medication, for Schizophrenia and acute BPAD
Vraylar Cariprazine Acute treatment of manic/mixed episodes of BPAD and Schizophrenia. ELDERLY PATIENTS WITH DEMENTIA RELATED PSYCHOSIS MUST NOT USE
Symproic Naldemedine For the treatment of opioid-induced constipation
Rhopressa Netarsudil To treat glaucoma or ocular hypertension
Austedo Deutetrabenazine For the treatment of chorea associated with Huntington’s disease
Xepi Ozenoxacin To treat impetigo
Sublocade Buprenorphine Once-monthly injectable partial opioid agonist formulation for the treatment of opioid use disorder
Fasenra Benralizumab For add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype
ZTlido Lidocaine ZTlido (lidocaine topical system 1.8%) is a transdermal anesthetic formulation for the treatment of pain associated with postherpetic neuralgia
Lonhala Magnair Glycopyrrolate Long-acting muscarinic antagonist (LAMA) bronchodilator for the long-term, maintenance treatment of COPD
Tymlos Abaloparatide To treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies
Radicava Edaravone To treat patients with amyotrophic lateral sclerosis (ALS)
Erleada Apalutamide Treatment of men with non-metastatic castration-resistant prostate cancer (CRPC)
Ozempic Semaglutide To improve glycemic control in adults with type 2 diabetes mellitus (DM)
Emflaza Deflazacort To treat patients age 5 years and older with Duchenne muscular dystrophy (DMD)
Ingrezza Valbenazine First and Only FDA-approved, to treat adults with tardive dyskinesia
Kevzara Sarilumab To treat adult rheumatoid arthritis
Cabometyx Cabozantinib To treat medullary thyroid cancer and treatment of patients with advanced renal cell carcinoma (RCC)
Repatha Evolocumab High Cholesterol; Prevention of Heart Attack and Stroke
Kisqali Ribociclib To treat postmenopausal women with a type of advanced breast cancer
Idhifa Enasidenib To treat relapsed or refractory acute myeloid leukemia
Trulance Plecanatide To treat Chronic Idiopathic Constipation (CIC) in adult patients
Giapreza Angiotensin II Treatment of hypotension in adults with septic or other distributive shock
Aliqopa Copanlisib To treat adults with relapsed follicular lymphoma
Parsabiv Etelcalcetide To treat secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing dialysis
Prexxartan Valsartan Treatment of hypertension, heart failure, and left ventricular dysfunction following myocardial infarction
Solosec Secnidazole To treat bacterial vaginosis
Verzenio Abemaciclib To treat certain advanced or metastatic breast cancers
Nerlynx Neratinib Maleate To reduce the risk of breast cancer returning
Symdeko Ivacaftor/Tezacaftor Treatment of Cystic Fibrosis in patients aged 12 and above
Mavyret Glecaprevir/ Pibrentasvir To treat adults with chronic hepatitis C virus
Soliris Eculizumab Treatment of patients with Generalized Myasthenia Gravis (GMG)
Xarelto Rivaroxaban Reduce the continued risk of venous thromboembolism (VTE)
Vabomere Meropenem/Vaborbactam To treat adults with complicated urinary tract infections
Apadaz Benzhydrocodone HCl/Acetaminophen Short-term management of acute pain
Zilretta Triamcinolone Acetonide A corticosteroid intra-articular injection indicated for the management of osteoarthritis pain of the knee
Steglujan Ertugliflozin/Sitagliptin Sodium glucose co-transporter 2 (SGLT2) inhibitor and biguanide combination used to improve glycemic control in adults with type 2 diabetes
Luxturna Voretigene Neparvovec An adeno-associated viral (AAV) vector gene therapy for the treatment of patients with vision loss due to confirmed biallelic RPE65-mediated inherited retinal disease (IRD)
Ixifi Infliximab-qbtx A tumor necrosis factor (TNF) blocker biosimilar to Remicade (infliximab) indicated for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis
Auryxia Ferric Citrate The control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. The treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis
Cotempla XR-ODT Methylphenidate First FDA-approved methylphenidate-based extended-release orally disintegrating tablet for the treatment of ADHD in children between the ages of 6 and 17